| |
| |
|
| Insider
Information: |
Shannon Timothy M |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
164,303 |
|
|
Indirect Shares
|
12,222,376 |
|
|
| Direct
Value |
$5,857,239 |
|
|
|
Indirect Value
|
$51,974,344 |
|
|
| Total
Shares |
12,386,679 |
|
|
| Total
Value |
$57,831,583 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
11
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-11.0
|
| Percentage
Gain/Loss : |
 80.9%
|
 -553.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celldex Therapeutics Inc |
CLDX |
Director |
2014-06-04 |
83,212 |
|
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
Director |
2016-11-29 |
448 |
2016-11-29 |
3,244,381 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Director |
2021-09-07 |
80,643 |
2021-09-07 |
1,653,128 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director |
2019-05-13 |
0 |
2019-05-13 |
2,254,442 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
Director |
2019-05-28 |
0 |
2019-05-28 |
2,660,713 |
Premium* |
|
|
Rallybio Corp |
RLYB |
Director |
2021-07-28 |
0 |
2021-08-02 |
2,409,712 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2009-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,212 |
|
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2009-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2010-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2011-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2012-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
79,212 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
81,212 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
83,212 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2015-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
4,884,755 |
1,318,418 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Director |
– • – |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
4,989,554 |
4,989,554 |
0 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • – |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,204,442 |
2,204,442 |
0 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,260,713 |
2,260,713 |
0 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,332,789 |
2,332,789 |
0 |
- |
|
| CLDX |
Celldex Therapeutics Inc |
Director |
– • – |
2010-09-10 |
4 |
B |
$3.41 |
$17,049 |
D/D |
5,000 |
100 |
2.39 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
|
• • – |
2016-05-24 |
4 |
S |
$10.00 |
$12,000 |
I/I |
(1,200) |
4,562,815 |
0 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Director |
– • – |
2019-05-28 |
4 |
B |
$10.00 |
$4,000,000 |
I/I |
400,000 |
2,660,713 |
2.1 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-06-06 |
4 |
S |
$10.01 |
$1,018,688 |
I/I |
(101,767) |
4,302,539 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-06-10 |
4 |
S |
$10.01 |
$27,027 |
I/I |
(2,700) |
4,244,381 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-05-25 |
4 |
S |
$10.02 |
$114,789 |
I/I |
(11,456) |
4,551,359 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-06-07 |
4 |
S |
$10.03 |
$97,602 |
I/I |
(9,731) |
4,292,808 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-06-09 |
4 |
S |
$10.06 |
$229,791 |
I/I |
(22,842) |
4,247,081 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-06-08 |
4 |
S |
$10.08 |
$230,681 |
I/I |
(22,885) |
4,269,923 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
|
• • – |
2016-05-20 |
4 |
S |
$10.09 |
$62,427 |
I/I |
(6,187) |
4,576,068 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
|
• • – |
2016-05-23 |
4 |
S |
$10.10 |
$121,735 |
I/I |
(12,053) |
4,564,015 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
|
• • – |
2016-05-19 |
4 |
S |
$10.14 |
$25,350 |
I/I |
(2,500) |
4,582,255 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Director |
– • – |
2016-05-26 |
4 |
S |
$10.43 |
$416,021 |
I/I |
(39,887) |
4,511,472 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
